WESTBRIDGE RESEARCH GROUP
NT 10-K, 1998-02-26
AGRICULTURAL CHEMICALS
Previous: INDEPENDENCE VARIABLE LIFE SEPARATE ACCOUNT, 24F-2NT, 1998-02-26
Next: HANCOCK JOHN SPECIAL EQUITIES FUND, 485BPOS, 1998-02-26



                                UNITED STATES
                    SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549


                       NOTIFICATION OF LATE FILING


(Check One): [x]Form 10-KSB [ ]Form 20-F [ ]Form 11-K [ ]Form 10Q [ ]Form N-SAR

     For Period Ended:    November 30, 1997

     [ x ] Transition Report on Form 10-KSB 
     [   ] Transition Report on Form 20-F 
     [   ] Transition  Report on Form 11-K 
     [   ] Transition  Report on Form 10-Q 
     [   ] Transition Report on Form N-SAR

     For the Transition Period Ended: _______________________________


Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates:


PART I - REGISTRANT INFORMATION

Full Name of Registrant:     

     Westbridge Research Group

Commission File No.:  2-92261

Employer ID Number:  95-3769474

Former Name, if applicable:

Address of Principal Executive Office (Street and Number):     

     1150 Joshua Way, Vista, CA 92083

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without  unreasonable effect or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed (Check box if appropriate).

      [x] (a)  The reasons  described in  reasonable  detail in Part III of this
form could not be eliminated without unreasonable effect or expense;

      [x] (b) The subject annual report,  semi-annual report, transition report
on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof,  will be filed on
or before the fifteenth  calendar day following the  prescribed due date; or the
subject  quarterly  report of transition  report on Form 10-Q or portion thereof
will be filed on or before the fifth calendar day following that  prescribed due
date; and

      [ ]  (c) The  accountant's  statement  or other  exhibit  required by Rule
12b-25(c) has been attached, if applicable.



<PAGE>


PART III - NARRATIVE

State below in  reasonable  detail the reasons  why the Form 10-K,  11-K,  10-Q,
N-SAR, or the transition  report, or portion thereof,  could not be filed within
the prescribed time period. (Attach Extra Sheets if Needed).

         Just completing  year-end audit and require  additional time to prepare
10-KSB and have it reviewed. Should be able to file by March 15, 1998.

PART IV - OTHER INFORMATION

     (1) Name and  telephone  number  of  person  to  contact  in regard to this
notification:

          Christine Koenemann, President
          (619) 599-8855

     (2) Have all other periodic  reports  required under Section 13 or 15(d) of
the Securities  Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the  preceding  12 months (or for such  shorter)  period that the
registrant  was  required to file such  reports)  been  filed?  If answer is no,
identify reports:

         [x] Yes     [ ] No


     (3) Is it anticipated that any significant  change in results of operations
from the corresponding  period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?

         [ ] Yes     [x] No

     If so, attach an explanation of the anticipated  change,  both  narratively
and  quantitatively,  and, if  appropriate,  state the reasons why a  reasonable
estimate of the results cannot be made.


                         WESTBRIDGE RESEARCH GROUP
                 Name of Registrant as Specified in Charter

has  caused  this  modification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.


Date: February 26, 1998                By:  /s/ Christine Koenemann
                                          -------------------------------------
                                          Christine Koenemann, President

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.


                                   ATTENTION

Intentional  misstatements  or omissions  of fact  constitute  Federal  Criminal
Violations (See 18 U.S.C. 1000).





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission